RET-IN-20
RET-IN-20 is a potent RET inhibitor with an IC50 value of 13.7 nM. RET-IN-20 decreases the expression of p-Ret, p-Shc protein. RET-IN-20 induces apoptosis. RET-IN-20 shows antiproliferative and anti-tumor activity[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; RET
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ret-in-20.html
Solubility
10 mM in DMSO
Smiles
COC1=C(C=C2C(N=CC=C2OC3=CC=C(C=C3F)NC4=NN(C=C4C(NC56CC7CC(C6)CC(C5)C7)=O)C)=C1)C(N)=O
Molecular Formula
C32H33FN6O4
Molecular Weight
584.64
References & Citations
[1]Zhang Y, et al. 1-Methyl-3- ((4- (quinolin-4-yloxy) phenyl) amino) -1H-pyrazole-4-carboxamide derivatives as new rearranged during Transfection (RET) kinase inhibitors capable of suppressing resistant mutants in solvent-front regions. Eur J Med Chem. 2022 Dec 15;244:114862.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
26300156 3x 1.0 µg DNA
LAPTM4A CRISPR All-in-one AAV vector set (with saCas9)(Rat)
Sign In for Pricing
View Details